Cautions Regarding the Fitting and Interpretation of Survival Curves: Examples from NICE Single Technology Appraisals of Drugs for Cancer

Author： Connock Martin  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.29, Iss.10, 2011-10, pp. : 827-837

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Single Technology Appraisals by NICE: Are They Delivering Faster Guidance to the NHS?

By Barham Leela  

PharmacoEconomics, Vol. 26, Iss. 12, 2008-01 ,pp. : 1037-1043

Adis International

Access to resources Recommend Favorite

Bevacizumab for Metastatic Colorectal Cancer: A NICE Single Technology Appraisal

By Whyte Sophie   Pandor Abdullah   Stevenson Matt  

PharmacoEconomics, Vol. 30, Iss. 12, 2012-12 ,pp. : 1119-1132

Adis International

Access to resources Recommend Favorite

NICE is seeking patient and carer input for health technology appraisals

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 268, 2000-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Recent NICE decisions for cancer drugs

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 637, 2011-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

NICE has increased its capacity for appraising new drugs and treatments, and will be able to review existing NICE appraisals more quickly

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 592, 2009-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite